Skip to main navigation Skip to search Skip to main content

Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: A factor for differing results of TPMT measurements

T. Kröplin, C. Fischer, H. Iven*

*Corresponding author for this work

Abstract

Objectives: Thiopurine S-methyltransferase (TPMT) activity, when measured in red blood cells (RBC) with a recently published TPMT activity assay using 6-thioguanine (6-TG) as substrate, could not be reproduced in another laboratory. We investigated factors which could influence the results of the TPMT activity measurement. Methods: We tested twelve 6-TG and four 6- mercaptopurine (6-MP) compounds from different suppliers as substrates and determined the enzyme kinetic parameters K(m) and V(max). Furthermore, we studied the influence of different 6-TG compounds on the affinity of the methyl donor S-adenosyl-L-methionine (SAM) to the TPMT enzyme. Results: All 6-TG products were of equal purity (declared > 98% by the supplier); this was ascertained by HPLC. However, the rate of methylation obtained following incubation with 6-TG from different suppliers ranged from 10% to 100% when incubated with the same RBC lysate. The lowest apparent K(m) value for a 6- TG was 22.3 gmol · 1-1, while the product with the highest methylation rate showed a K(m) of 156 μmol · 1-1. From these results we assume that there is a contaminant in some 6-TG products, which acts as a strong inhibitor of TPMT activity. Compounds possibly used for the synthesis of 6- TG (guanine, pyridine, 6-chloroguanine) did not affect the methylation rate. Thioxanthine, which is known to be a strong inhibitor of TPMT when added to the assay system to give a 2% contamination, reduced TPMT activity from 100% to 72%. Using 6-MP from different suppliers as substrate resulted in K(m) values ranging from 110 to 162 (max)mol · 1-1 and V(max) values ranging from 54 to 68 nmol 6-MMP · g-1Hb · h-1. The K(m) value for the methyl donor SAM was similar to and independent from the thiopurine substrates tested (range 4.9-11 (max)mol · 1-1 SAM). In contrast to other investigators, we found nonenzymatic S-methylation, which was negligible under our assay conditions (3% with 128 (max)mol · 1-1 SAM), but could become relevant in experiments using higher SAM concentrations. Conclusions: TPMT enzyme activity determined with 6-TG as substrate may be strongly inhibited by a contaminant in some of the 6-TG lots distributed.

Original languageEnglish
JournalEuropean Journal of Clinical Pharmacology
Volume55
Issue number4
Pages (from-to)285-291
Number of pages7
ISSN0031-6970
DOIs
Publication statusPublished - 03.07.1999

Funding

Acknowledgements The authors would like to thank Georg He-inkele and Frank Schönberger for their assistance and Dr. G. B. Elion for helpful suggestions. The generous gift of 6-TG from Glaxo Wellcome is appreciated. The work was supported in part by the Robert Bosch Foundation.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Research Areas and Centers

  • Academic Focus: Biomedical Engineering

Fingerprint

Dive into the research topics of 'Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: A factor for differing results of TPMT measurements'. Together they form a unique fingerprint.

Cite this